Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06108037 · ClinicalTrials.gov registry record · NA

DHL Survey on Generative AI for MyChart Messaging

A NA study of Communication, sponsored by Duke University.

Completed
Registry status
NA
Development phase
1,454
Enrollment target
1
Study location

NCT06108037 is a NA study of Communication that has completed, run by Duke University. The registered enrollment target is 1,454 participants, roughly in line with the 1,378-participant average among 34 other Communication trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06108037, a NA study of Communication, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
1,454 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand how patients feel about the use of computer programs to create responses when they send electronic messages to their doctors.

Conditions Studied

Interventions

  • BEHAVIORAL Generative AI for electronic communication and disclosure

Study Locations (1)

North Carolina

  • Duke University Health System - Durham

Trial Details

FieldValue
Enrollment Target 1,454 participants
Start Date 2023-10-31
Est. Completion 2023-12-11
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06108037

The ClinicalTrials.gov registry entry for NCT06108037 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,454 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,378-participant average among 34 other Communication trials with a reported enrollment target. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Communication appearing as the primary indexed condition, and to 1 intervention - of which Generative AI for electronic communication and disclosure is the first listed.

NCT06108037 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06108037 about?

NCT06108037 is a clinical study titled "DHL Survey on Generative AI for MyChart Messaging". The purpose of this study is to understand how patients feel about the use of computer programs to create responses when they send electronic messages to their doctors.

What is the current status of trial NCT06108037?

This trial is currently completed. It is a NA study. The enrollment target is 1,454 participants. The study started on 2023-10-31. Estimated completion is 2023-12-11.

What conditions does trial NCT06108037 study?

This clinical trial studies the following conditions: Communication.

What interventions are being tested in trial NCT06108037?

The interventions under investigation include: Generative AI for electronic communication and disclosure (BEHAVIORAL).

Who is sponsoring clinical trial NCT06108037?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06108037 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.